MeiraGTx UK II Ltd.
Subsidiary Company
Follow
View Corporate Tree
Create Alert
Basic Info
Headquarter
United Kingdom
Founded Year
2014
Social Media
https://www.athena-vision.com
MeiraGTx UK II Ltd. is a company that provides Retinal Disorder, Lampalizumab, Angiogenesis inhibitor and more. MeiraGTx UK II Ltd. is headquartered in United Kingdom . MeiraGTx UK II Ltd. was founded in 2014. MeiraGTx UK II Ltd. has a total of 228 patents
Related Topics
Login to view all basic info
Innovation Word Cloud
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of MeiraGTx UK II Ltd.
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by MeiraGTx UK II Ltd.
Market Category
Pharmaceuticals
Market Segment
Optical Disorders Drugs
Related Company
Related Market Sectors
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for MeiraGTx UK II Ltd.
Time Range:
Overall
Application Domain L2
Tech Topic L2
Download
Subsidiary Lists
Subsidiaries with patent applications for MeiraGTx UK II Ltd.
Sign up to view the full dataFree Trial Now
MeiraGTx UK II Ltd. Frequently Asked Questions
What technical fields has MeiraGTx UK II Ltd. researched?
What is MeiraGTx UK II Ltd.'s total number of patents?
What kind of company is MeiraGTx UK II Ltd.?
Part of MeiraGTx Holdings Plc, MeiraGTx UK II Ltd. is a British company located in London that develops novel gene-based therapies for retinal disorders...
Show all question
Related Companies
Changi General Hospital Pte Ltd.Central Region, Singapore
Ozgene Pty Ltd.Western Australia, Australia
FibrogenesisTexas, United States
BioClinica, Inc.Pennsylvania, United States
Apogee Biotechnology Corp.Pennsylvania, United States
Cilag AGSchaffhausen, Switzerland
Emmi Solutions LLCIllinois, United States
Kura Oncology, Inc.California, United States
Nacuity Pharmaceuticals, Inc.Texas, United States
Login to view all
Hot Companies in Industries
Popular
Retinal Disorder
Lampalizumab
Angiogenesis inhibitor
Clinical trial
ShopifyRedditTik tokAppleSquarespaceSoundcloudMediumParallelsZoomGoogleGodaddyMicrosoftForbesEtsyHuawei TechnologiesYandexAmazonEvent briteDribbbleHatenaWalmartWPengineUberSplunkServiceNowTwilioHubSpotMuleSoftBloombergCargill
Sequenom, Inc.Croma-Pharma GmbHTearScience, Inc.D.O.R.C. Dutch Ophthalmic Research Center (International) BVRainbow Medical Ltd.Samsara Vision, Inc.Graybug Vision, Inc.Sight Sciences, Inc.Oxurion NVShanghai Haohai Biological Technology Co., Ltd.IMI Intelligent Medical Implants AGGNT Pharma Co., Ltd.Oasis Medical, Inc.ExonhitVasoptic Medical, Inc.Eyenuk, Inc.Epipole Ltd.SAV-IOL SA
Shanghai Jiao Tong UniversityOsaka UniversityUCL Business Ltd.RWTH Aachen UniversityUniversité Catholique de LouvainGunma UniversityAchillion Pharmaceuticals, Inc.Syracuse UniversityAerpio Therapeutics, Inc.NeXstar Pharmaceuticals, Inc.Loyola University of ChicagoIllinois Institute of TechnologyRa Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc.Proteostasis Therapeutics, Inc.Kala Pharmaceuticals, Inc.Neovacs SABiokine Therapeutics Ltd.Prolynx LLCOcuNexus Therapeutics, Inc.Kodiak Sciences, Inc.Alteogen, Inc.Verseon Corp.Biophytis SAGenaera Corp.Lpath, Inc.Gene Signal International SAApexigen America, Inc.PolyActiva Pty Ltd.Araim Pharmaceuticals, Inc.
Shanghai Jiao Tong UniversityOsaka UniversityUCL Business Ltd.RWTH Aachen UniversityUniversité Catholique de LouvainGunma UniversityAchillion Pharmaceuticals, Inc.Syracuse UniversityAerpio Therapeutics, Inc.NeXstar Pharmaceuticals, Inc.Loyola University of ChicagoIllinois Institute of TechnologyRa Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc.Proteostasis Therapeutics, Inc.Kala Pharmaceuticals, Inc.Neovacs SABiokine Therapeutics Ltd.Prolynx LLCOcuNexus Therapeutics, Inc.Kodiak Sciences, Inc.Alteogen, Inc.Verseon Corp.Biophytis SAGenaera Corp.Lpath, Inc.Gene Signal International SAApexigen America, Inc.PolyActiva Pty Ltd.Araim Pharmaceuticals, Inc.
Takeda Pharmaceutical Co., Ltd.Bayer HealthCare Pharmaceuticals, Inc.Bristol Myers Squibb Co.Sanofi A/SNovo Nordisk A/SAmgen, Inc.Baxter International, Inc.Nippon Kayaku Co., Ltd.CJ CheilJedang Corp.Japan Tobacco, Inc.Regeneron Pharmaceuticals, Inc.Chugai Pharmaceutical Co., Ltd.Les Laboratoires Servier SASShionogi & Co., Ltd.Gilead Sciences, Inc.Yeda Research & Development Co. Ltd.Grünenthal GmbHSumitomo Pharma Co., Ltd.Ionis Pharmaceuticals, Inc.Ono Pharmaceutical Co., Ltd.Celgene Corp.CHIESI Farmaceutici SpASigma-Tau Industrie Farmaceutiche Riunite SpATachi-S Co., Ltd.New York UniversityUCB SABTG Ltd.ZymoGenetics, Inc.Technion Research & Development Foundation Ltd.Immatics Biotechnologies GmbH
View more
People also Viewed
Zhejiang Hongtian Copper competitorsLudwig-Maximilians-Universit?t München competitorsWeld Tooling competitorsGaptec 2011 company profileWuhan Hesheng Automotive Parts patentsKorea Institute of Energy Research competitorsZhonghao Ziyun TechnologyZhejiang Rifeng Electrical AppliancesAsia Dragon Electric company profileEznix company profileWarwick HRI competitorsArios patentsVitro Flat Glass patentsEpirusHMI Industries patentsShenzhen Bento Electronic TechnologyZhejiang Maizi Hosiery TechnologyStarTrak Systems company profileZhongxi Jujube Technology Engineering CenterTaizhou Yonglin MachineryJinan Baihui Kaixi Auto Parts company profileDeutsche EdelstahlwerkeCanon IT SolutionsNIPPNTaizhou Weihua Coating Technology patentsQingdao Double Whale Pharmaceutical patentsZhongshan Shesheng Electronics company profileQingdao Institute of Bioenergy and Processes, Chinese Academy of Sciences patentsInnoven Energy company profileLuoyang Douzhi Sprout Agricultural Technology
Page generation time: Feb 19 2023